Previous Close | 125.80 |
Open | 127.16 |
Bid | 187.90 |
Ask | 196.00 |
Strike | 855.00 |
Expire Date | 2024-08-16 |
Day's Range | 125.30 - 127.16 |
Contract Range | N/A |
Volume | |
Open Interest | 9 |
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...
There hasn't been a new COPD treatment in years. But Regeneron stock analysts are closely watching a pair of key FDA decisions.
Regeneron stock joined the 1,000-club this month as enthusiasm grows for its blockbuster drug, Dupixent, in COPD treatment.